Suchergebnisse - "Saussele, S"

PubPharm (13)

1

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

enthalten in: Leukemia | 2020

von Hochhaus, A. | Baccarani, M. | Silver, R. | +31

2

Safety and efficacy of imatinib in CML over a period of 10 years : data from the randomized CML-study IV

enthalten in: Leukemia | 2015

von Kalmanti, L. | Saussele, S. | Lauseker, M. | +22

CommentIn: AAPS J. 2016 Jul;18(4):914-22. - PMID 27007600

3

Management of chronic myeloid leukemia in blast crisis

enthalten in: Annals of hematology | 2015

von Saußele, S. | Silver, R.

4

Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib

enthalten in: Leukemia | 2014

von Hanfstein, B. | Shlyakhto, V. | Lauseker, M. | +27

5

MDR1 expression predicts outcome of Ph+ chronic phase CML patients on second-line nilotinib therapy after imatinib failure

enthalten in: Leukemia | 2014

von Agrawal, M. | Hanfstein, B. | Erben, P. | +10

6

Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)

enthalten in: Leukemia | 2012

von Hanfstein, B. | Müller, M. | Hehlmann, R. | +31

7

Treatment of chronic myeloid leukemia in blast crisis

enthalten in: Haematologica | 2008

von Hehlmann, R. | Saussele, S.

CommentOn: Haematologica. 2008 Dec;93(12):1792-6. - PMID 18838477

8

Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probes

enthalten in: Leukemia | 2000

von Saussele, S. | Weisser, A. | Müller, M. | +7

9

Detection and quantification of residual disease in chronic myelogenous leukemia

enthalten in: Leukemia | 2000

von Hochhaus, A. | Weisser, A. | La Rosée, P. | +8

10

Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia : low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML Study Group

enthalten in: Blood | 2000

von Hochhaus, A. | Reiter, A. | Saussele, S. | +10